Drug utilization and prescribing pattern in the treatment of urolithiasis: a perspective on World Health Organization recommendations

Mudassir Sada; Sania Khan; M. Umar Khan; M. Muazzam Khan; Pankaj Kumar; Usama Ahmad

doi:10.18203/2319-2003.ijbcp20240994

Authors

Mudassir Sada Department of Pharmacy Practice, Integral University, Lucknow, Uttar Pradesh, India https://orcid.org/0009-0002-2537-8424
Sania Khan Department of Pharmacy Practice, Integral University, Lucknow, Uttar Pradesh, India
M. Umar Khan Department of Pharmacy Practice, Integral University, Lucknow, Uttar Pradesh, India
M. Muazzam Khan Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, India https://orcid.org/0000-0002-5561-9308
Pankaj Kumar Department of General Surgery, Integral Institute of Medical Science and Research Hospital, Lucknow, Uttar Pradesh, India
Usama Ahmad Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20240994

Keywords:

Urolithiasis, Drug utilization, Prescribing pattern, Kidney stones, Prescribing indicators

Abstract

Background: Drug utilization research (DUR) is essential in promoting rational use of medicine, aimed at understanding the patterns of prescription, administration, and utilization of medications. It provides valuable insights into the actual drug usage patterns for specific disease conditions. To evaluate the current utilization pattern of drugs in patients of urolithiasis in the Department of General Medicine and Surgery at Integral Institute of Medical Science and Research Hospital, Lucknow.

Methods: Following the approval of the institutional ethics committee, a prospective observational study was conducted at Integral Institute of Medical Science and Research Department of general medicine and surgery over a six-month period. Urolithiasis patients’ prescriptions were analyzed to study the prescribing patterns. Information about patient demographics, co-morbidities, and the number and types of medications prescribed were collected and analyzed.

Results: Out of 102 patients studied, a female preponderance over male patients was observed. The co-morbidities that are encountered most commonly were hydronephrosis, cystitis, and renal cyst. There is averaged 7 medicines per prescription, 15.25% of medicines written by the generic name, 83.33% of patients receiving antibiotics, 54.70% of patients receiving injections, and 83% of drugs prescribed are mentioned in the essential medicine list. Analgesics, antibiotics, nutritional supplements, antiemetic, alkalizing agents, and antispasmodics were among the class of medicines given.

Conclusions: This study highlights the current use of medicines and drug utilization in urolithiasis management. The findings show important insights for healthcare professionals to enhance medication therapy, encourage cost-effective healthcare delivery and improve quality of patient in urolithiasis management.

Metrics

Metrics Loading ...

References

Hess B. Renal stone clinic survey: calcium stone formers’ self-declared understanding of and adherence to physician’s recommendations. Urolithiasis. 2017;45(4):363-70.

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380(9859):2095-128.

Chung MJ. Urolithiasis and nephrolithiasis. JAAPA. 2017;30(9):49-50.

Scales Jr CD, Smith AC, Hanley JM, Saigal CS, Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160-5.

Izzedine H, Lescure FX, Bonnet F. HIV medication-based urolithiasis. Clin Kidney J. 2014;7(2):121-6.

Schaeffer AJ, Feng Z, Trock BJ, Mathews RI, Neu AM, et al. Medical comorbidities associated with pediatric kidney stone disease. Urology. 2011;77(1):195-9.

Courbebaisse M, Prot-Bertoye C, Bertocchio JP, Baron S, Maruani G, Briand S, et al. Nephrolithiasis of adult: From mechanisms to preventive medical treatment. La Revue de Medecine Interne. 2016;38(1):44-52.

Stamatelou K, Goldfarb DS. Epidemiology of kidney stones. Healthcare. 2023;11(3):424.

Ware EB, Smith JA, Zhao W, Ganesvoort RT, Curhan GC, Pollak M, et al. Genome-wide Association Study of 24-Hour Urinary Excretion of Calcium, Magnesium, and Uric Acid. Mayo Clinic Proceedings: Innovations, Quality & Outcomes. 2019;3(4):448-60.

Bishop K, Momah T, Ricks J. Nephrolithiasis. Primary Care: Clinics in Office Practice. 2020;47(4):661-71.

Preminger GM. Chapter 148: Stones in the urinary tract. Cutler, RE. The Merck Manual of Medical Information Home Edition. 2007.

Qaader DS, Yousif SY, Mahdi LK. Prevalence and etiology of urinary stones in hospitalized patients in Baghdad. Eastern Mediterranean Health J. 2006;12(6):853-61.

Baowaidan F, Zugail AS, Lyoubi Y, Culty T, Lebdai S, Brassart E, et al. Incidence and risk factors for urolithiasis recurrence after endourological management of kidney stones: A retrospective single-centre study. Progrès en Urologie. 2022;32(8-9):601-7.

Geraghty RM, Davis NF, Tzelves L, Lombardo R, Yuan C, Thomas K, et al A. Best practice in interventional management of urolithiasis: an update from the European Association of Urology Guidelines Panel for Urolithiasis 2022. Eur Urol Focus. 2023;9(1):199-208.

Tefera BB, Getachew M, Kebede B. Evaluation of drug prescription pattern using World Health Organization prescribing indicators in public health facilities found in Ethiopia: systematic reviews and meta-analysis. J Pharm Policy Pract. 2021;14:1-10.

World Health Organization. Introduction to Drug Utilization Research. 2003. Available at: https://www. who.int/publications/i/item/8280820396. Accessed on 15 May 2023.

Ministry of Health and Family Welfare, Gov’t of India. National List of Essential Medicines (NLEM). 2022. Available at: https://main.mohfw.gov.in/?q= newshighlights-104. Accessed on 15 May 2023.

World Health Organization. WHO Model List of Essential Medicines – 23rd List. 2023. Available at: https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02. Accessed on 29 July 2023.

El Mahalli AA. WHO/INRUD drug prescribing indicators at primary health care centres in Eastern province, Saudi Arabia. EMHJ-Eastern Mediterranean Health J. 2012;18(11):1091-6.

Türk C, Knoll T, Petrik A, Sarica K, Straub M, Seitz C. Guidelines on urolithiasis. European Association of Urology. 2011. Available at: https://uroweb.org/ guidelines/urolithiasis/chapter/guidelines. Accessed on 29 July 2023.

Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L, et al. Prevalence of kidney stones in China: an ultrasonography based cross‐sectional study. BJU Int. 2017;120(1):109-16.

Faridi MS, Singh KS. Preliminary study of prevalence of urolithiasis in North-Eastern city of India. J Fam Med Prim Care. 2020;9(12):5939-43.

Khalili P, Jamali Z, Sadeghi T, Esmaeili-Nadimi A, Mohamadi M, Moghadam-Ahmadi A, et al. Risk factors of kidney stone disease: a cross-sectional study in the southeast of Iran. BMC Urol. 2021;21:1-8.

Liu M, Wu J, Xia W, Zhu Z, Chen H. Lifestyle factors, serum parameters, metabolic comorbidities, and the risk of kidney stones: a Mendelian randomization study. Front Endocrinol. 2023;14:1240171.

Grover S, Srivastava A, Lee R, Tewari AK, Te AE. Role of inflammation in bladder function and interstitial cystitis. Therap Adv Urol. 2011;3(1):19-33.

Navya TK, Hazra P, Padma L. Audit of prescriptions from the department of general medicine based on the WHO core prescribing indicators at Sapthagiri hospital, Bangalore. Int J Basic Clin Pharmacol. 2019;8(12):2759-62.

Ahmad A, Tausif M, Biswas N, Aftab M. Study of drug utilization pattern for acne vulgaris in the department of dermatology at integral institute of medical sciences and research. Eur Chem Bull. 2023;12(10):6279-89.

Gottlieb M, Long B, Koyfman A. The evaluation and management of urolithiasis in the ED: A review of the literature. Am J Emerg Med. 2018;36(4):699-706.

Atray P, Haque I, Jangra S. Evaluation of Drug Prescribing Pattern in Chronic Kidney Disease Patients at Tertiary Care Hospital in Northern India-an Observational Study. WJPPS. 2021;10(2):1222-32.

Kamath L, NG H. A study of drug utilisation pattern in patients of chronic kidney disease at a tertiary care hospital. Int J Basic Clin Pharmacol. 2019;8(2):170-5.

Khushtar, Singh M, Khushtar M, Ajmal M, Shamveel M. Drug utilization pattern and adverse drug reaction monitoring of drugs used in typhoid at a tertiary care hospital: a prospective observational study. World J Pharm Pharm Sci. 2023;12(7):1462-70.

Naqvi S, Ahmad M, Akhter M, Yadav A, Singh A, Ahmad J, et al. Drug Utilization Pattern and Adverse Drug Reaction Monitoring of Antibiotics Use in Ear, Nose and Throat Infection at Tertiary Care Hospital, Lucknow, India. Authorea Preprints. 2023;19.

Ahmad M, Ahmad MA, Siddiqui MA. Suspected ADR monitoring and comparative assessment of antidiabetic drugs on glycemic control in type 2 diabetic patients. Authorea Preprints. 2023;14.

Khan AW. A Study of Prescription Pattern in Musculoskeletal Disorders causing Low Back Pain (LBP) in a Tertiary Care Teaching Hospital in Northern India. Int J Toxicol Pharmacol Res. 2023;13(9):132-9.

Golzari SE, Soleimanpour H, Rahmani F, Mehr NZ, Safari S, Heshmat Y, et al. Therapeutic approaches for renal colic in the emergency department: a review article. Anesthesiol Pain Med. 2014;4:1.